Efficacy of Tezepelumab in Severe, Uncontrolled Asthma: Pooled Analysis of PATHWAY and NAVIGATOR Studies.
Sign Up to like & getrecommendations! Published in 2023 at "American journal of respiratory and critical care medicine"
DOI: 10.1164/rccm.202210-2005oc
Abstract: RATIONALE Tezepelumab reduced exacerbations in patients with severe, uncontrolled asthma across a range of baseline blood eosinophil counts (BECs) and fractional exhaled nitric oxide (FeNO) levels, and irrespective of allergy status, in the phase 2b… read more here.
Keywords: severe uncontrolled; uncontrolled asthma; pooled analysis; pathway navigator ... See more keywords